Clinical trial
Post Transplant Donor Lymphocyte Infusion
NCT00167180 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00167180 |
|---|---|
| Title | Post Transplant Donor Lymphocyte Infusion |
| Official title | Use of Cyclophosphamide/Fludarabine to Promote in Vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy After Allogeneic Transplant |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myeloid, Chronic, Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, Lymphocytic, Acute, AML |
| Intervention type | Drug, Procedure |
| Interventions | Donor Lymphocyte Infusion, Induction Chemotherapy |
| Enrollment | 57 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 21, 2017 |
| Completion | Dec 24, 2018 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: